apricot & span

31
APRICOT & SPAN Dunblane, 25 April 2014

Upload: bill

Post on 19-Jan-2016

72 views

Category:

Documents


0 download

DESCRIPTION

APRICOT & SPAN. Dunblane, 25 April 2014. APRICOT - SPAN. Overview What is APRICOT? Why SPAN? How to participate Results & follow-up. APRICOT. A naesthesia Pr actice I n C hildren O bservational T rial - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: APRICOT & SPAN

APRICOT & SPAN

Dunblane, 25 April 2014

Page 2: APRICOT & SPAN

APRICOT - SPAN

Overview• What is APRICOT?• Why SPAN?• How to participate• Results & follow-up

Page 3: APRICOT & SPAN

APRICOT

[email protected]@gmail.com

Anaesthesia Practice In Children Observational Trial

European prospective multicenter observational study: Epidemiology of severe critical events

Page 4: APRICOT & SPAN

APRICOT

Aims

• Incidence of severe critical events in children undergoing anesthesia in Europe

• Differences in paediatric anaesthesia practice• Impact of this variability on the occurrence of severe

critical events • Improve the quality and safety of anaesthesia in

children

Page 5: APRICOT & SPAN

APRICOT

DesignProspective, observational, multi–centre cohort study

Inclusion

All children (0-16 years) admitted for any elective/non-elective inpatient or outpatient procedure (general anaesthesia, sedation with or without regional analgesia)

ExclusionChildren admitted to theatres from PICU or procedures in PICU/NICU(include if spontaneous ventilation or non-intubated on CPAP)

Page 6: APRICOT & SPAN

APRICOT

Primary Endpoint

Incidence of severe critical events during and up to 60 minutes after anaesthesia

Page 7: APRICOT & SPAN

Severe critical events

Laryngospasm Bronchospasm

Stridor Pulmonary aspiration

Drug error Anaphylaxis

Cardiovascular instability Cardiac arrest

Neurological damage

Page 8: APRICOT & SPAN

DefinitionsSevere critical events (CRF 1.4)

Page 9: APRICOT & SPAN

APRICOT

Primary EndpointIncidence of severe critical events during and up to 60 minutes after anaesthesia

Secondary EndpointsRisk factorsConsequences/ outcomes

Sample Size25,000 children Europe wide

Page 10: APRICOT & SPAN

Sponsor & CI

ESA Clinical Trials NetworkChief Investigator: Prof Walid HabreUK National Coordinator: Dr Neil Morton

Page 11: APRICOT & SPAN

Endorsements- ESPA

- Association of Paediatric Anaesthetists of Great Britain and Ireland (APAGBI)

- Association of French speaking Paediatric Anaesthetists and Intensivists (Association des Anesthésiste-Réanimateurs Pédiatriques d’expression française (ADARPEF-),

- Swiss Society for Paediatric Anaesthesiology (Schweizerische Gesellschaft für Kinderanästhesie / Société Suisse d’Anesthésiologie Pédiatrique (SGKA/SSAP)),

- Italian Society for Paediatric and Neonatal Anaesthesia and Intensive Care (La Società di Anestesia e Rianimazione Neonatale e Pediatrica Italiana (S.A.R.N.eP.I.)),

- German Society of Anesthesiology and Intensive Care Medicine (Deutsche Gesellschaft für Anästhesiologie und lntensivmedizin e.V." (DGAI)),

- The Belgian Association for Paediatric Anaesthesiology (BAPA),

- Society of Anesthesia and Resuscitation of Belgium (SARB),

- Austrian Society of Anesthesiology (Österreichische Gesellschaft für Anaesthesiologie, Reanimation und Intensivmedizin) (ÖGARI),

- Hellenic Society of Anaesthesiology - Greece (EAE)

- Ukrainian Society of Anesthesiologists - Ассоциация анестезиологов Украины – Ukraine (AAY)

Page 12: APRICOT & SPAN

Centres

>300 centres72 UK centresAll Scottish centres in SPAN signed up

Page 13: APRICOT & SPAN

UK Study conditions

Observational non-research studyData anonymised and protectedEthics waiverWaiver of individual patient consentCaldicott guardian and R&D approvalsFamily information leaflets and posters

Page 14: APRICOT & SPAN

WHY SPAN ?

• Unique national picture to inform and educate for the future

• Opportunity to measure against the whole European dataset

• Plan & model future studies SPAN/ UK / Europe

Page 15: APRICOT & SPAN

WHO has signed up?

Page 16: APRICOT & SPAN

HOW to participate

• Initial steps – registration (ESA/AAGBI membership)

• Date setting01 April 2014 - 31 December 2014

• Ethics not required – Audit (WOSRES)• Caldicott• Paper work and logistical issues

Page 17: APRICOT & SPAN

Everyone needs to be involved!(but only for 2 weeks)

Page 18: APRICOT & SPAN

Paperwork

• Email from ESA confirming registration– Your contact details including ESA/AAGBI membership

• Site questionnaire (www.surveymonkey.com/s/APRICOTSTUDY )

• Cover sheet, WOSRES notification, Information leaflet

Page 19: APRICOT & SPAN

Cover sheet, WOSRES, Information

Page 20: APRICOT & SPAN

Paperwork

• Email from ESA confirming registration• Site questionnaire (www.surveymonkey.com/s/APRICOTSTUDY )

• Cover sheet, WOSRES notification, Information leaflet• ESA /UK notification of start date (8 days minimum)

• Case Report Form (CRF 1.4.1) – print one per patient

Page 21: APRICOT & SPAN

• Cover per patient

Case Report Form - v 1.4.1 only

Page 22: APRICOT & SPAN

Case Report Form - v 1.4.1 only

• Cover• Preoperative data• Intraoperative data• Perioperative complications• Postanaesthetic data

Page 23: APRICOT & SPAN

• Cover• Preoperative data– Demographics– Medical history– Indication– Anaesthesia Plan

Case Report Form - v 1.4.1 only

Page 24: APRICOT & SPAN

• Cover• Preoperative data• Intraoperative data– Type of anaesthesia (sedation, GA, RA)– Airway management– Ventilation– Fluids– Timing

Case Report Form - v 1.4.1 only

Page 25: APRICOT & SPAN

• Cover• Preoperative data• Intraoperative data• Perioperative complications

Case Report Form - v 1.4.1 only

Page 26: APRICOT & SPAN

• Cover• Preoperative data• Intraoperative data• Perioperative complications• Postanaesthetic data

Case Report Form - v 1.4.1 only

Page 27: APRICOT & SPAN

Paperwork

• Email from ESA confirming registration• Cover sheet, WOSRES notification• Site questionnaire (www.surveymonkey.com/s/APRICOTSTUDY )

• ESA /UK notification of start date (8 days minimum)

• Case Report Form (CRF 1.4) – print one per patient • eCRF upload (Open Clinica electronic CRF)

• FAQ – in email response from ESA

Page 28: APRICOT & SPAN

FAQ

Page 29: APRICOT & SPAN

Results & Follow-up

Overall results to paper for LancetBenchmarking against overall results– by country– by centre– opportunity for complete national picture for Scotland

QI projects (pain management and others)

Page 30: APRICOT & SPAN

Contacts & copies of talk

Dr Lesley McKee: [email protected] Neil Morton: [email protected] Dr Thomas Engelhardt: [email protected]

Page 31: APRICOT & SPAN

APA - SPA joint meetingAberdeen, Scotland 14-15th May 2015

CCAN - CCAS joint meeting Aberdeen, Scotland 13th May 2015